Benign Prostatic HyperplasiaNCT07507123
VR Discharge Education After TURP
A study testing Discharge Education in people with Benign Prostatic Hyperplasia and Transurethral Resection of the Prostate (TURP), run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled trial evaluated the effect of virtual reality-assisted discharge education on readiness for hospital discharge among patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Benign Prostatic Hyperplasia, Transurethral Resection of the Prostate (TURP)
- What is being tested?
- Discharge Education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 68 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2024to 15 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Being able to speak and understand Turkish
- Being literate
- Being over 18 years of age
Who cannot join
- Having a visual or hearing impairment
- Having previously undergone TURP
- Being a member of the healthcare staff
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Aydın Adnan Menderes University
Efeler, Aydın, 09090
About this study
Official title: Effect of Virtual Reality-Assisted Discharge Education on Readiness for Hospital Discharge Following Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Controlled Trial
This randomized controlled trial evaluated the effect of virtual reality-assisted discharge education on readiness for hospital discharge among patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.
Read the detailed description
This randomized controlled trial aimed to evaluate the effect of virtual reality-based discharge education on patients' readiness for hospital discharge after TURP for benign prostatic hyperplasia. Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.
- Being tested
- Discharge Education
- Keywords
- Benign Prostatic Hyperplasia, TURP, Virtual Reality, Discharge Education, Readiness for Hospital Discharge, Patient Education
- Medical subject headings
- Prostatic Hyperplasia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Discharge EducationOther
Intervention Group: Virtual Reality-Based Discharge Education
In addition to standard perioperative education, patients in the intervention group received a virtual reality-based educational intervention before surgery. This intervention was delivered in the urology clinic's procedure room using VR headsets and consisted of an approximately structured educational video covering postoperative care and discharge-related information. The aim was to provide an immersive and interactive learning experience to enhance patient understanding and preparedness. As in the control group, readiness for hospital discharge was assessed prior to discharge using the same validated instrument.
| Study group | Role | What they receive |
|---|---|---|
| Experimental group (Discharge education) | Experimental | In addition to routine discharge education, patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia received a virtual reality-assisted discharge education approximately two hours before surgery. The intervention was delivered individually in the urology clinic using an Oculus Quest 2 VR headset and consisted of a standardized 17-minute educational video covering postoperative self-care, including catheter care, bleeding management, pain management, nutrition, mobilization, medication use, warning signs requiring medical attention, and home care after discharge. Participants completed the Readiness for Hospital Discharge Scale-Short Form (RHDS-SF) before surgery (baseline) and again immediately before hospital discharge. Receives: Other: Discharge Education |
| Control group (Placebo) | No intervention | Patients allocated to the control group received routine discharge education approximately two hours before surgery, consistent with standard clinical practice. The education was delivered verbally by the ward nurse and included information on catheter care, medication use, and seeking medical attention in the event of postoperative bleeding. No additional educational intervention or VR-assisted education was provided. Participants completed the Readiness for Hospital Discharge Scale-Short Form (RHDS-SF) before surgery (baseline) and again immediately before hospital discharge. Following completion of outcome assessment, patients in the control group were offered access to the VR educational video for ethical reasons. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Readiness for Discharge Scale - Patient Self-Assessment Form
This scale, which allows patients to assess their own readiness for discharge, consists of eight items and four subscales. Adapted into Turkish by Kaya and colleagues in 2017, this scale features questions parallel to those in the nursing version. The scale has a Cronbach's alpha value of 0.74 and employs a 10-point Likert-type rating scale.
Measured: Before surgery (baseline)
Secondary outcomes (1)
Readiness for Discharge Scale - Patient Self-Assessment Form
This scale, which allows patients to assess their own readiness for discharge, consists of eight items and four subscales. Adapted into Turkish by Kaya and colleagues in 2017, this scale features questions parallel to those in the nursing version. The scale has a Cronbach's alpha value of 0.74 and employs a 10-point Likert-type rating scale.
Measured: Second postoperative day, immediately before hospital discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Apr 2026
- Study start15 May 2024
- Primary completion15 Nov 2024
- Study completion15 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Benign Prostatic HyperplasiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 68 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aydin Adnan Menderes University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hilal Hatice Ülkü, Aydin Adnan Menderes University
- Investigators
- HiLAL H ÜLKÜ, PhD, Study chair, Aydin Adnan Menderes University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07507123
- Sponsor's protocol ID
- VR Discharge Education
- Status last verified
- Aug 2026
- First submitted
- 24 Mar 2026
- Last updated
- 2 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request
Study at a glance
From the registry record, last updated by the sponsor on 2 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Virtual Reality-Assisted Discharge Education on Readiness for Hospital Discharge Following Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07507123
- Acronym / sponsor ID
- VR Discharge Education
- Keywords
- Benign Prostatic Hyperplasia, TURP, Virtual Reality, Discharge Education, Readiness for Hospital Discharge, Patient Education
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 68 participants (actual)
- Lead sponsor
- Aydin Adnan Menderes UniversityUniversity, hospital or other
- Study start
- 15 May 2024 (actual)
- Primary completion
- 15 Nov 2024 (actual)
- Study completion
- 15 Nov 2024 (actual)
- First posted
- 2 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial evaluated the effect of virtual reality-assisted discharge education on readiness for hospital discharge among patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.
Detailed description
This randomized controlled trial aimed to evaluate the effect of virtual reality-based discharge education on patients' readiness for hospital discharge after TURP for benign prostatic hyperplasia. Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental group (Discharge education) | Experimental | Other: Discharge EducationIn addition to routine discharge education, patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia received a virtual reality-assisted discharge education approximately two hours before surgery. The intervention was delivered individually in the urology clinic using an Oculus Quest 2 VR headset and consisted of a standardized 17-minute educational video covering postoperative self-care, including catheter care, bleeding management, pain management, nutrition, mobilization, medication use, warning signs requiring medical attention, and home care after discharge. Participants completed the Readiness for Hospital Discharge Scale-Short Form (RHDS-SF) before surgery (baseline) and again immediately before hospital discharge. |
| Control group (Placebo) | No intervention | –Patients allocated to the control group received routine discharge education approximately two hours before surgery, consistent with standard clinical practice. The education was delivered verbally by the ward nurse and included information on catheter care, medication use, and seeking medical attention in the event of postoperative bleeding. No additional educational intervention or VR-assisted education was provided. Participants completed the Readiness for Hospital Discharge Scale-Short Form (RHDS-SF) before surgery (baseline) and again immediately before hospital discharge. Following completion of outcome assessment, patients in the control group were offered access to the VR educational video for ethical reasons. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Being able to speak and understand Turkish
- Being literate
- Being over 18 years of age
Key exclusion criteria (3 listed)
- Having a visual or hearing impairment
- Having previously undergone TURP
- Being a member of the healthcare staff
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Discharge EducationIntervention Group: Virtual Reality-Based Discharge Education In addition to standard perioperative education, patients in the intervention group received a virtual reality-based educational intervention before surgery. This intervention was delivered in the urology clinic's procedure room using VR headsets and consisted of an approximately structured educational video covering postoperative care and discharge-related information. The aim was to provide an immersive and interactive learning experience to enhance patient understanding and preparedness. As in the control group, readiness for hospital discharge was assessed prior to discharge using the same validated instrument. | Other | Experimental group (Discharge education) |
Primary outcome
Readiness for Discharge Scale - Patient Self-Assessment Form
Time frame: Before surgery (baseline)
This scale, which allows patients to assess their own readiness for discharge, consists of eight items and four subscales. Adapted into Turkish by Kaya and colleagues in 2017, this scale features questions parallel to those in the nursing version. The scale has a Cronbach's alpha value of 0.74 and employs a 10-point Likert-type rating scale.
1 secondary outcome
Readiness for Discharge Scale - Patient Self-Assessment Form
Time frame: Second postoperative day, immediately before hospital discharge
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Sep 2026.
- Individual participant dataSharing planned: Yes. The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request
Related trials for Benign Prostatic Hyperplasia
Active, not recruitingPhase 1/2
RT-310 Safety and Feasibility BPH Study
BPH (Benign Prostatic Hyperplasia)
RecruitingPhase 2
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Urinary Urge Incontinence, Stress Urinary Incontinence
Not yet recruiting
Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Recruiting
Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)
BPH (Benign Prostatic Hyperplasia)
Recruiting
Comparing Rezum and Urolift
Benign Prostatic Hyperplasia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
HiLAL H ÜLKÜ, PhD study chair
Aydin Adnan Menderes University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Discharge Education in people with Benign Prostatic Hyperplasia and Transurethral Resection of the Prostate (TURP), run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Readiness for Discharge Scale - Patient Self-Assessment Form (time frame: Before surgery (baseline)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2026.